Bristol-Myers Squibb Company;Université de Montréal
发明人:
BANVILLE JACQUES,RÉMILLARD ROGER,RUEDIGER EDWARD H.,DEON DANIEL H.,GAGNON MARC,DUBÉ LAURENCE,GUY JULIA,PRIESTLEY ELDON SCOTT,POSY SHOSHANA L.,MAXWELL BRAD D.,WONG PANCRAS C.,LAWRENCE MICHAEL R.,MILLER,GUY
申请号：
PL13721857
公开号：
PL2841437T3
申请日:
2013.04.24
申请国别(地区):
PL
年份:
2017
代理人:
摘要：
The present invention provides thiazole compounds of Formula I wherein W, Y, R 0 , R 2 , R 4 , R 5 , R 6 , R 7 , X 1 , X 2 , X 3 and X 4 are as defined herein, or a stereoisomer, tautomer, pharmaceutically acceptable salt or solvate form thereof, wherein all of the variables are as defined herein. These compounds are inhibitors of platelet aggregation and thus can be used as medicaments for treating or preventing thromboembolic disorders.
